Skip to main content
. 2015 Sep 29;12(5):7412–7418. doi: 10.3892/mmr.2015.4387

Fig. 1.

Fig. 1

Isoflurane suppresses proliferation in a p53-dependent manner. (A) The results of the methyl thiazolyl tetrazolium assay indicated that isoflurane inhibited the proliferation of WT NSCs in a dose-dependent manner (**P<0.01 compared with the non-treated group; n=3). (B) A significant inhibition of proliferation was observed at all the time points (**P<0.01 compared with the non-treated group; n=3). (C) Isoflurane fails to induce any significant cell cycle arrest in the absence of p53−/− NE-4C cells (*P<0.05; #P>0.05 compared with the non-treated group; n=3). (D) The percentage of cells in the G0/G1 phase in WT NSCs treated with the IC50 concentration of isoflurane was greater compared with that in the untreated group. This did not apply for the p53−/− NE-4C cells (**P<0.01;*P<0.05; #P>0.05 compared with the non-treated group; n=3). NSCs, neural stem cells.